Leading US immunologist to talk at RDS

HOW DOCTORS involved in medical research can learn a great deal from their own patients is the theme of a free public talk to…

HOW DOCTORS involved in medical research can learn a great deal from their own patients is the theme of a free public talk to be giving next month at the RDS Dublin by leading US immunologist, Prof John O’Shea.

The title for his presentation is: Learning from patients: how rare diseases inform immunology.

Prof O’Shea is the 2009 recipient of the Irish Society for Immunology Public Lecture Award. Each year the society celebrates an outstanding immunologist in recognition of their contribution to the understanding of immunology.

The recipient is always asked to deliver a free public talk, organised by the RDS and The Irish Times in association with the Irish Society for Immunology, and this year’s talk by Prof O’Shea will be in the Merrion Room of the RDS.

He speaks with considerable authority as the scientific director of the Molecular Immunology and Inflammation Branch in the US National Institutes of Health. This centre looks at the underlying biochemical causes of common, debilitating auto-immune diseases such as rheumatoid arthritis.

Prof O’Shea will discuss two rare immunodeficiency diseases to illustrate his talk. Learning the molecular basis of these diseases has offered new insights into ways to tackle related diseases by developing new immunosuppressant drugs to counter them.

The talk takes place at 7pm on May 21st. The event is free but space is limited so those wishing to attend are asked to book by emailing a request to science@rds.ie or by telephone on 01-2407289.

  • Join The Irish Times on WhatsApp and stay up to date

  • Sign up for push alerts to get the best breaking news, analysis and comment delivered directly to your phone

  • Listen to In The News podcast daily for a deep dive on the stories that matter

Dick Ahlstrom

Dick Ahlstrom

Dick Ahlstrom, a contributor to The Irish Times, is the newspaper's former Science Editor.